Moderna | MRNA - Interest Income


Moderna reported $73M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Biogen USD 31.6M 700K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Celltrion KRW 676.66M 6.85B Jun/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Moderna USD 73M 8M Sep/2025
Pharma Mar EUR 4.8M 6.4M Dec/2024
Puma Biotechnology USD 0.41 0.5 Sep/2024
Qiagen NV USD 15.07M 1.21M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025